CEO: Jacqualyn A. Fouse

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.


Key numbers

Market Capitalization:2395305440
Shares Outstanding: 67133000
Float: 66443678.356000006
Next Earning Date:2020-02-13
TTm EPS: -6.8464
TTm Dividend Rate:
200 days moving average:47.71
50 days moving average: 34.04
One day percent Change: 3.19



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,